Latest News
Biocon's Drug Trial Not Good Enough For COVID-19 Mortality Reduction: ICMR
After the Indian Council of Medical Research (ICMR) allowed the emergency use of the two drugs Itolizumab and Tocilizumab to treat COVID-19 patients, the Director-General of the medical body, Balram Bhargava, has acknowledged that there is no evidence from clinical trials of the two drugs that it...